Evolution of the Average Target: DexCom, Inc.

Evolution of the Target Price: DexCom, Inc.

Changes in Analyst Recommendations: DexCom, Inc.

519fd96f4ff02.jItpuuN_DylUM802L_ri4qYl92Src9hpKZSmUVKAeZI.w-8u0ZYpa1EnQLVpRo7XielRzwWYHq4KGe7KB2DMMcbcyTr52kxHECxfvg~85a44ba852e7a395831194493b876476
13/08 Citigroup Adjusts Price Target on DexCom to $105 From $88, Maintains Buy Rating MT
04/08 Argus Adjusts Price Target on DexCom to $96 From $86, Maintains Buy Rating MT
03/08 UBS Adjusts Price Target on DexCom to $102 From $96, Maintains Buy Rating MT
03/08 Rothschild & Co Redburn Adjusts Price Target on DexCom to $100 From $90, Maintains Buy Rating MT
31/07 DexCom Glucose Monitors' National Coverage Could Support H2 Upside, RBC Capital Markets Says MT
31/07 Leerink Partners Adjusts Price Target on DexCom to $94 From $80, Maintains Outperform Rating MT
31/07 RBC Raises Price Target on DexCom to $90 From $85, Keeps Outperform Rating MT
31/07 Canaccord Genuity Adjusts Price Target on DexCom to $90 From $82, Maintains Buy Rating MT
31/07 Evercore ISI Adjusts Price Target on DexCom to $100 From $90, Maintains Outperform Rating MT
31/07 Mizuho Adjusts Price Target on DexCom to $95 From $90, Maintains Outperform Rating MT
31/07 Benchmark Adjusts Price Target on DexCom to $82 From $77, Maintains Buy Rating MT
31/07 Bernstein Adjusts Price Target on DexCom to $90 From $77, Maintains Outperform Rating MT
31/07 Deutsche Bank Adjusts DexCom Price Target to $92 From $86, Maintains Buy Rating MT
31/07 Truist Raises Price Target on DexCom to $93 From $87, Keeps Buy Rating MT
31/07 Baird Adjusts Price Target on DexCom to $105 From $80, Maintains Outperform Rating MT
31/07 JPMorgan Adjusts Price Target on DexCom to $82 From $65, Maintains Neutral Rating MT
31/07 Piper Sandler Adjusts Price Target on DexCom to $95 From $88, Maintains Overweight Rating MT
31/07 Wells Fargo Adjusts Price Target on DexCom to $90 From $85, Maintains Overweight Rating MT
31/07 Stifel Adjusts Price Target on DexCom to $95 From $90, Maintains Buy Rating MT
31/07 Citigroup Adjusts Price Target on DexCom to $88 From $84, Maintains Buy Rating MT
31/07 Jefferies Adjusts Price Target on DexCom to $115 From $112, Maintains Buy Rating MT
31/07 BTIG Adjusts Price Target on DexCom to $90 From $80, Maintains Buy Rating MT
31/07 Raymond James Adjusts Price Target on DexCom to $94 From $91, Maintains Strong Buy Rating MT
31/07 Analyst recommendations: Apple, Baxter International, Dexcom, Flex, Humana, Stellantis… Zonebourse
28/07 UBS Adjusts Price Target on DexCom to $96 From $95, Maintains Buy Rating MT

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
+2.89%
+7.31%
+8.68%
+20.18%
+15.04%
+6.84%
+25.39%
+16.92%
+17.65%
+11.46%
Average +13.24%
Weighted average by Cap. +11.11%
See all sector consensus

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
91.48USD
Average target price
94.12USD
Spread / Average Target
+2.89%
High Price Target
115.00USD
Spread / Highest target
+25.71%
Low Price Target
79.00USD
Spread / Lowest Target
-13.64%

Analyst Consensus Detail

Consensus revision (last 18 months)

Analysts covering the company

Citigroup
Argus
UBS
Rothschild & Co Redburn
Leerink Partners
RBC Capital Markets
Wells Fargo Securities
Stifel Nicolaus
Piper Sandler
JPMorgan Chase
Baird
Truist Securities
Deutsche Bank Securities
Bernstein
Benchmark Company
Mizuho Securities
Evercore ISI
Canaccord Genuity
Jefferies & Co.
BTIG
Raymond James
TD Cowen
Goldman Sachs
BofA Securities
Barclays
Morgan Stanley
Wolfe Research
Oppenheimer
Redburn Atlantic
Nephron Research
Cowen
SVB Leerink
Haywood Securities
Berenberg Bank
Guggenheim
Atlantic Equities
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
91.48USD
Average target price
94.12USD
Spread / Average Target
+2.89%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. DXCM Stock
  4. Consensus DexCom, Inc.